1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29200
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWong A.en
dc.date.accessioned2021-05-14T09:51:29Zen
dc.date.available2021-05-14T09:51:29Zen
dc.date.copyright2020en
dc.date.created20200730en
dc.date.issued2020-07-30en
dc.identifier.citationEMA - Emergency Medicine Australasia. 32 (4) (pp 697-699), 2020. Date of Publication: 01 Aug 2020.en
dc.identifier.issn1742-6731en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/29200en
dc.description.abstractSince December 2019, coronavirus disease (COVID-19) has been increasingly spreading from its origin in Wuhan, China to many countries around the world eventuating in morbidity and mortality affecting millions of people. This pandemic has proven to be a challenge given that there is no immediate cure, no vaccine is currently available and medications or treatments being used are still undergoing clinical trials. There have already been examples of self-medication and overdose. Clearly, there is a need to further define the efficacy of treatments used in the management of COVID-19. This evidence needs to be backed by large randomised-controlled clinical trials. In the meantime, there will no doubt be further off-label use of these medications by patients and practitioners and possibly related toxicity.Copyright © 2020 Australasian College for Emergency Medicineen
dc.languageenen
dc.languageEnglishen
dc.publisherBlackwell Publishingen
dc.relation.ispartofEMA - Emergency Medicine Australasiaen
dc.subject.meshbone marrow suppression-
dc.subject.meshChina-
dc.subject.meshcoma-
dc.subject.meshconvulsion-
dc.subject.meshcoronavirus disease 2019-
dc.subject.meshdiarrhea-
dc.subject.meshdrug efficacy-
dc.subject.meshdrug overdose-
dc.subject.meshdrug research-
dc.subject.meshevidence based medicine-
dc.subject.meshgastrointestinal symptom-
dc.subject.meshheadache-
dc.subject.meshheart arrhythmia-
dc.subject.meshhypertransaminasemia-
dc.subject.meshhypokalemia-
dc.subject.meshhypotension-
dc.subject.meshkidney dysfunction-
dc.subject.meshliver injury-
dc.subject.meshpancreatitis-
dc.subject.meshpandemic-
dc.subject.meshpatient safety-
dc.subject.meshQT prolongation-
dc.subject.meshrash-
dc.subject.meshself medication-
dc.subject.meshvirus load-
dc.subject.meshvirus transmission-
dc.subject.meshactivated carbon-
dc.subject.meshazithromycin [Adverse Drug Reaction]-
dc.subject.meshdrug intoxication-
dc.subject.meshazithromycin-
dc.subject.meshceftriaxone-
dc.subject.meshchloroquine [Adverse Drug Reaction]-
dc.subject.meshchloroquine-
dc.subject.meshatrioventricular block-
dc.subject.meshcolchicine-
dc.subject.meshhydroxychloroquine [Adverse Drug Reaction]-
dc.subject.meshhydroxychloroquine-
dc.subject.meshivermectin-
dc.subject.meshlopinavir plus ritonavir [Adverse Drug Reaction]-
dc.subject.meshlopinavir plus ritonavir-
dc.subject.meshremdesivir [Adverse Drug Reaction]-
dc.subject.meshremdesivir-
dc.subject.meshthalidomide-
dc.subject.meshtocilizumab [Adverse Drug Reaction]-
dc.subject.meshtocilizumab-
dc.titleCOVID-19 and toxicity from potential treatments: Panacea or poison.en
dc.typeArticleen
dc.identifier.affiliationMonash University - School of Clinical Sciences at Monash Health-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/1742-6723.13537-
dc.publisher.placeAustraliaen
dc.identifier.pubmedid32378805 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32378805]en
dc.identifier.source2004900692en
dc.identifier.institution(Wong) Victorian Poisons Information Centre, Austin Toxicology Unit and Emergency Department, Austin Health, Melbourne, VIC, Australia (Wong) Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia (Wong) Centre for Integrated Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australiaen
dc.description.addressA. Wong, Victorian Poisons Information Centre, Austin Toxicology Unit and Emergency Department, Austin Health, Melbourne, VIC, Australia. E-mail: anselm.wong@austin.org.au A. Wong, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia. E-mail: anselm.wong@austin.org.au A. Wong, Centre for Integrated Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia. E-mail: anselm.wong@austin.org.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.subect.keywordscoronavirus COVID overdose toxicologyen
dc.identifier.authoremailWong A.; anselm.wong@austin.org.auen
dc.description.grantNo: 1159907 Organization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australiaen
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
crisitem.author.deptRadiology-
Appears in Collections:Articles
Show simple item record

Page view(s)

44
checked on Sep 11, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.